v3 Template
G

GangaGen

Biotechnology / Healthcare ~420 employees
Founded
--
Employees (Est.)
~420
21 leaders known
Total Funding
$7.9M
Funding Rounds
1
Last Funding
2024-12-19

About GangaGen

GangaGen is focused on engineering novel treatments for drug-resistant bacterial infections, aiming to address critical challenges in combating antibiotic resistance.

Products & Services

Protein Antibacterials:Innovative treatments targeting bacterial infections using protein-based approaches.
Bacteriocins:Antimicrobial peptides produced by bacteria to inhibit the growth of similar or related bacterial strains.
Lysins:Enzymes that break down bacterial cell walls as a method to combat infections.
Ectolysin:A specific type of lysin-based treatment for bacterial infections.
P128:A targeted antibacterial protein under development for treating infections.
Bacteriophages:Viruses that infect and kill bacteria, used as a therapeutic approach for infections.
Novel Applications:Innovative uses of bacteriophages and related technologies for bacterial control.
Services:Specialized offerings in antibacterial research and development.
Collaborative Research:Partnerships and joint research initiatives to develop new treatments for bacterial infections.

Specialties

Drug-resistant bacterial infections Protein antibacterials Bacteriophages Lysins Antimicrobial research

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant
A: 7900000
MR: -
FA: US$7.9M
FAN: 7900000
D: 2024-12-19
FD: 2024-12-19
1 investors
Grant Latest
2024-12-19
$7.9M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

D

David Melnick

Chief Medical Officer

G

Gautam Sanyal

Member

M

Margaret Riley

Member

A

Alexander Burton

Full Stack Software Developer, Web Developer, and Mentor

T

T. S. Balganesh

President, GBPL and Member, Board of Directors, GBPL

A

Ajith Kamath

Board of Directors, GBPL

View 18 more team members with Pro

Unlock Full Team Directory

Recent News

GangaGen Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~420 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro